FSD Pharma - Advisor, Kevin Harrington.
Advisor, Kevin Harrington.
Source: As Seen On TV.
  • FSD Pharma (HUGE) has appointed entrepreneur Kevin Harrington to its advisory board
  • Harrington is known as the inventor of the infomercial, pioneer of the As Seen on TV brand, and one of the original members of ABC’s Shark Tank
  • As an advisor to FSD, he will work to expand the company’s brands through his vast contact network
  • FSD Pharma is a biotechnology company developing drug candidates for inflammatory diseases, drug abuse, neurodegenerative disorders and mental health disorders
  • FSD Pharma (HUGE) is up by 5.65 per cent, trading at $2.43 per share

FSD Pharma (HUGE) has appointed entrepreneur Kevin Harrington to its advisory board.

Harrington is known as the inventor of the infomercial, pioneer of the As Seen on TV brand, and one of the original members of ABC’s Shark Tank.

He has launched over 20 businesses with individual sales in excess of $100 million, introduced over 1,000 products, and opened distribution outlets in over 100 countries throughout his career.

He also co-founded the Entrepreneurs’ Organization, a network of over 17,000 business leaders with 220 chapters in over 60 countries.

As an advisor to FSD, Harrington will work to expand the company’s brands through his vast contact network.

“Kevin has always been a visionary at the forefront of the dynamic marketing space, proving over decades the tremendous value he brings to companies he becomes involved with by sharing his branding expertise, network, and business insight,” stated Zeeshan Saeed, FSD’s President and Co-Executive Chairman.

“Throughout my career, my investments have the common thread of ground-floor opportunities in research and development of products that I believe can be transformational, whether it be a beverage, kitchen utensil, or, in the case of FSD Pharma, a strong pipeline of therapeutics, which include potential products that may provide significant help in alcohol misuse cases,” added Harrington.

FSD Pharma is a biotechnology company developing drug candidates for inflammatory diseases, drug abuse, neurodegenerative disorders and mental health disorders.

FSD Pharma (HUGE) is up by 5.65 per cent, trading at $2.43 per share as of 10:16 am EST.


More From The Market Online

Myriad Uranium secures mining lease at Copper Mountain

Myriad Uranium (CSE:M) has entered into a 20-year mining lease with Diamond X Ranch for the Copper Mountain Uranium Project.

@ the Bell: Global markets make a comeback, but gold sinks

Canada’s main stock index followed markets around the globe on Monday and marched higher, recouping some losses from the dud of a week prior.

Eric Sprott tops up investment in gold stock Rio2

Eric Sprott adds C$2,000,115 to his position in Rio2 (TSXV:RIO), a junior mining stock developing its Fenix gold project in Chile.